Improving brain health in patients with immune thrombotic thrombocytopenic purpura
Official title: Targeting silent cerebral infarction to improve long-term neurologic outcomes in immune thrombotic thrombocytopenic purpura (iTTP)
Funded at Johns Hopkins University · NIH-10816664 · Data updated 2026-11-12
This study is looking at how surviving a rare blood disorder called immune thrombotic thrombocytopenic purpura (iTTP) might affect brain health over time, especially focusing on hidden brain injuries that can happen without any noticeable symptoms, to help find ways to keep your brain healthy after treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | August 27, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $438,682 |
| NIH project number | 1R00HL172303-01 |
| Project ID | NIH-10816664 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older who have been diagnosed with immune thrombotic thrombocytopenic purpura.
✕Less likely to help
Patients who do not have a diagnosis of immune thrombotic thrombocytopenic purpura are unlikely to benefit from this research.
What this research studies
This research investigates the long-term neurological outcomes in patients who have survived immune thrombotic thrombocytopenic purpura (iTTP), a rare blood disorder. It focuses on understanding silent cerebral infarctions, which are brain injuries that occur without obvious symptoms, and their potential impact on cognitive function and stroke risk. The study will involve multiple clinical sites and aims to determine whether these brain injuries occur during remission or only after acute episodes of iTTP. By identifying the incidence and risk factors for these silent infarctions, the research seeks to develop strategies to prevent them and improve overall brain health in affected patients.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for cognitive impairment and stroke in iTTP survivors.
How similar studies have gone: Previous research has shown a high prevalence of silent cerebral infarctions in iTTP survivors, indicating that this area of investigation is both relevant and necessary.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Chaturvedi, Shruti — Johns Hopkins University
- Study coordinator: Chaturvedi, Shruti
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Targeting silent brain infarcts to improve neurologic outcomes in iTTP
A multi-center study looks at hidden brain injuries in adults with immune thrombotic thrombocytopenic purpura (iTTP) and what it means for their long-term brain health.
-
Preventing silent brain infarcts in people who survived immune TTP
This project looks at whether finding and preventing small, symptom-free brain infarcts can protect thinking and lower stroke risk in adults who survived immune thrombotic thrombocytopenic purpura (iTTP).
-
Investigating how type I interferon helps restore blood-brain barrier function after a stroke
This study is looking at how a certain signaling process in the body can help repair the brain's protective barrier after a stroke, with the hope that the findings will lead to new ways to support recovery for stroke patients.
-
Erlangen Stroke Registry: A long-running look at stroke in a German community
This registry is testing how stroke cases are collected and followed over time in Erlangen to understand how many people are affected and how care evolves.
-
Early Identification of BAD-related Stroke in Adults
This study tests how well a multisource AI diagnostic approach can identify BAD-related stroke among adults with acute ischemic stroke within a week of onset.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.